Literature DB >> 7984418

Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide.

J P Bongartz1, A M Aubertin, P G Milhaud, B Lebleu.   

Abstract

Recently several groups reported a dramatic improvement of reporter gene transfection efficiency using a fusogenic peptide, derived from the Influenza hemagglutinin envelop protein. This peptide changes conformation at acidic pH and destabilizes the endosomal membranes thus resulting in an increased cytoplasmic gene delivery. We describe the use of a similar fusogenic peptide in order to improve the antiviral potency of antisense oligodeoxynucleotides (anti TAT) and oligophosphorothioates (S-dC28) on de novo HIV infected CEM-SS lymphocytes in serum-free medium. We observed as 5 to 10 fold improvement of the anti HIV activities of the phosphodiester antisense oligonucleotides after chemical coupling to the peptide in a one to one ratio by a disulfide or thioether bond. No toxicities were observed at the effective doses (0.1-1 microM). No sequence specificity was obtained and the fusogenic peptide possessed some antiviral activities on its own (IC50: 6 microM). A S-dC28-peptide disulfide linked conjugate and a streptavidin-peptide-biotinylated S-dC28 adduct showed similar activities as the free S-dC28 oligonucleotide (IC50: 0.1-1 nM). As expected, all the compounds were less potent in the presence of serum but the relative contribution of peptide coupling was maintained.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7984418      PMCID: PMC308518          DOI: 10.1093/nar/22.22.4681

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  34 in total

1.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

Authors:  P L Felgner; T R Gadek; M Holm; R Roman; H W Chan; M Wenz; J P Northrop; G M Ringold; M Danielsen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  pH-dependent membrane fusion activity of a synthetic twenty amino acid peptide with the same sequence as that of the hydrophobic segment of influenza virus hemagglutinin.

Authors:  M Murata; Y Sugahara; S Takahashi; S Ohnishi
Journal:  J Biochem       Date:  1987-10       Impact factor: 3.387

3.  Proton-induced membrane fusion. Role of phospholipid composition and protein-mediated intermembrane contact.

Authors:  J Bondeson; J Wijkander; R Sundler
Journal:  Biochim Biophys Acta       Date:  1984-10-17

4.  Nycodenz: a new nonionic iodinated gradient medium.

Authors:  D Rickwood; T Ford; J Graham
Journal:  Anal Biochem       Date:  1982-06       Impact factor: 3.365

5.  Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides.

Authors:  J Goodchild; S Agrawal; M P Civeira; P S Sarin; D Sun; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

6.  Anti-human immunodeficiency virus activities of the beta-L enantiomer of 2',3'-dideoxycytidine and its 5-fluoro derivative in vitro.

Authors:  G Gosselin; R F Schinazi; J P Sommadossi; C Mathé; M C Bergogne; A M Aubertin; A Kirn; J L Imbach
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

7.  Bicyclic imidazo derivatives, a new class of highly selective inhibitors for the human immunodeficiency virus type 1.

Authors:  C Moog; A Wick; P Le Ber; A Kirn; A M Aubertin
Journal:  Antiviral Res       Date:  1994-08       Impact factor: 5.970

8.  Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes.

Authors:  R J Cristiano; L C Smith; S L Woo
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

9.  Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.

Authors:  M Matsukura; K Shinozuka; G Zon; H Mitsuya; M Reitz; J S Cohen; S Broder
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

10.  Oligodeoxynucleotide stability in subcellular extracts and culture media.

Authors:  E Wickstrom
Journal:  J Biochem Biophys Methods       Date:  1986-09
View more
  25 in total

1.  Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotides.

Authors:  C Pichon; M B Roufaï; M Monsigny; P Midoux
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  Delivery of oligonucleotides into mammalian cells by anionic peptides: comparison between monomeric and dimeric peptides.

Authors:  I Freulon; A C Roche; M Monsigny; R Mayer
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

Review 3.  Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides.

Authors:  R L Juliano; S Alahari; H Yoo; R Kole; M Cho
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

4.  The spherulites(TM): a promising carrier for oligonucleotide delivery.

Authors:  N Mignet; A Brun; C Degert; B Delord; D Roux; C Hélène; R Laversanne; J C François
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

5.  Stepwise synthesis of RNA conjugates carrying peptide sequences for RNA interference studies.

Authors:  Anna Aviñó; Sandra M Ocampo; Clara Caminal; José Carlos Perales; Ramon Eritja
Journal:  Mol Divers       Date:  2009-02-03       Impact factor: 2.943

6.  Peptide antisense nanoparticles.

Authors:  Pinal C Patel; David A Giljohann; Dwight S Seferos; Chad A Mirkin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-11       Impact factor: 11.205

7.  Characterization of peptide-oligonucleotide heteroconjugates by mass spectrometry.

Authors:  O N Jensen; S Kulkarni; J V Aldrich; D F Barofsky
Journal:  Nucleic Acids Res       Date:  1996-10-01       Impact factor: 16.971

8.  Construction and characterization of novel, completely human serine protease therapeutics targeting Her2/neu.

Authors:  Yu Cao; Khalid A Mohamedali; John W Marks; Lawrence H Cheung; Walter N Hittelman; Michael G Rosenblum
Journal:  Mol Cancer Ther       Date:  2013-03-14       Impact factor: 6.261

9.  Use of 1,2,4-dithiazolidine-3,5-dione (DtsNH) and 3-ethoxy-1,2,4-dithiazoline-5-one (EDITH) for synthesis of phosphorothioate-containing oligodeoxyribonucleotides.

Authors:  Q Xu; K Musier-Forsyth; R P Hammer; G Barany
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

Review 10.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.